Literature DB >> 22761427

Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer.

Hyun Min Jung1, Brittany L Phillips, Rushi S Patel, Donald M Cohen, Andrew Jakymiw, William W Kong, Jin Q Cheng, Edward K L Chan.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that posttranscriptionally regulate gene expression during many biological processes. Recently, the aberrant expressions of miRNAs have become a major focus in cancer research. The purpose of this study was to identify deregulated miRNAs in oral cancer and further focus on specific miRNAs that were related to patient survival. Here, we report that miRNA expression profiling provided more precise information when oral squamous cell carcinomas were subcategorized on the basis of clinicopathological parameters (tumor primary site, histological subtype, tumor stage, and HPV16 status). An innovative radar chart analysis method was developed to depict subcategories of cancers taking into consideration the expression patterns of multiple miRNAs combined with the clinicopathological parameters. Keratinization of tumors and the high expression of miR-21 were the major factors related to the poor prognosis of patients. Interestingly, a majority of the keratinized tumors expressed high levels of miR-21. Further investigations demonstrated the regulation of the tumor suppressor gene reversion-inducing cysteine-rich protein with kazal motifs (RECK) by two keratinization-associated miRNAs, miR-7 and miR-21. Transfection of miR-7 and miR-21-mimics reduced the expression of RECK through direct miRNA-mediated regulation, and these miRNAs were inversely correlated with RECK in CAL 27 orthotopic xenograft tumors. Furthermore, a similar inverse correlation was demonstrated in CAL 27 cells treated in vitro by different external stimuli such as trypsinization, cell density, and serum concentration. Taken together, our data show that keratinization is associated with poor prognosis of oral cancer patients and keratinization-associated miRNAs mediate deregulation of RECK which may contribute to the aggressiveness of tumors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22761427      PMCID: PMC3436145          DOI: 10.1074/jbc.M112.366518

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity.

Authors:  H Hiratsuka; A Miyakawa; K Nakamori; Y Kido; H Sunakawa; G Kohama
Journal:  Cancer       Date:  1997-08-01       Impact factor: 6.860

2.  Lymph node metastases in hamster tongue cancer induced with 9,10-dimethyl-1,2-benzanthracene: association between histological findings and the incidence of neck metastases, and the clinical implications for patients with tongue cancer.

Authors:  Y Take; M Umeda; O Teranobu; K Shimada
Journal:  Br J Oral Maxillofac Surg       Date:  1999-02       Impact factor: 1.651

3.  Changes in keratin expression during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis.

Authors:  I B Gimenez-Conti; D M Shin; A B Bianchi; D R Roop; W K Hong; C J Conti; T J Slaga
Journal:  Cancer Res       Date:  1990-07-15       Impact factor: 12.701

4.  Prognostic significance of keratinization in nasopharyngeal carcinoma.

Authors:  S P Reddy; W F Raslan; S Gooneratne; S Kathuria; J E Marks
Journal:  Am J Otolaryngol       Date:  1995 Mar-Apr       Impact factor: 1.808

5.  RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.

Authors:  Toshihiko Masui; Ryuichiro Doi; Takatomo Koshiba; Koji Fujimoto; Shoichiro Tsuji; Sanae Nakajima; Masayuki Koizumi; Eiji Toyoda; Sidhartha Tulachan; Daisuke Ito; Kazuhiro Kami; Tomohiko Mori; Michihiko Wada; Makoto Noda; Masayuki Imamura
Journal:  Clin Cancer Res       Date:  2003-05       Impact factor: 12.531

6.  The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.

Authors:  Taku Takeuchi; Michiyoshi Hisanaga; Mitsuo Nagao; Naoya Ikeda; Hisao Fujii; Fumikazu Koyama; Tomohide Mukogawa; Hiroshi Matsumoto; Shunya Kondo; Chiaki Takahashi; Makoto Noda; Yoshiyuki Nakajima
Journal:  Clin Cancer Res       Date:  2004-08-15       Impact factor: 12.531

Review 7.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

8.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression.

Authors:  Christine H Chung; Joel S Parker; Gamze Karaca; Junyuan Wu; William K Funkhouser; Dominic Moore; Dale Butterfoss; Dong Xiang; Adam Zanation; Xiaoying Yin; William W Shockley; Mark C Weissler; Lynn G Dressler; Carol G Shores; Wendell G Yarbrough; Charles M Perou
Journal:  Cancer Cell       Date:  2004-05       Impact factor: 31.743

10.  Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK.

Authors:  C Takahashi; Z Sheng; T P Horan; H Kitayama; M Maki; K Hitomi; Y Kitaura; S Takai; R M Sasahara; A Horimoto; Y Ikawa; B J Ratzkin; T Arakawa; M Noda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

View more
  46 in total

1.  Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies.

Authors:  Juliana I Santos; Ana L Teixeira; Francisca Dias; Joaquina Maurício; Francisco Lobo; António Morais; Rui Medeiros
Journal:  Tumour Biol       Date:  2014-04-24

2.  microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.

Authors:  Yi Pan; Hongwei Liang; Weixu Chen; Hongjie Zhang; Nan Wang; Feng Wang; Suyang Zhang; Yanqing Liu; Chihao Zhao; Xin Yan; Junfeng Zhang; Chen-Yu Zhang; Hongwei Gu; Ke Zen; Xi Chen
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

3.  CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma.

Authors:  Yuk Pheel Park; Linchun Jin; Katie B Bennett; Dunrui Wang; Kristianna M Fredenburg; Jennifer E Tseng; Lung-Ji Chang; Jianping Huang; Edward K L Chan
Journal:  Oral Oncol       Date:  2018-02-20       Impact factor: 5.337

4.  Interleukin 1β-Responsive MicroRNA-146a Is Critical for the Cytokine-Induced Tolerance and Cross-Tolerance to Toll-Like Receptor Ligands.

Authors:  Md A Nahid; Minoru Satoh; Edward K L Chan
Journal:  J Innate Immun       Date:  2015-04-18       Impact factor: 7.349

Review 5.  MicroRNA-21 gene and cancer.

Authors:  Yong Huang; You Bing Yang; Xiao Hui Zhang; Xue Li Yu; Zhan Bin Wang; Xiang Chao Cheng
Journal:  Med Oncol       Date:  2013-01-01       Impact factor: 3.064

Review 6.  Non-coding RNAs deregulation in oral squamous cell carcinoma: advances and challenges.

Authors:  T Yu; C Li; Z Wang; K Liu; C Xu; Q Yang; Y Tang; Y Wu
Journal:  Clin Transl Oncol       Date:  2015-09-14       Impact factor: 3.405

7.  MiR-25 promotes gastric cancer cells growth and motility by targeting RECK.

Authors:  Hongying Zhao; Yu Wang; Liu Yang; Rongke Jiang; Wenqing Li
Journal:  Mol Cell Biochem       Date:  2014-01       Impact factor: 3.396

Review 8.  Targeting M3 Muscarinic Receptors for Colon Cancer Therapy.

Authors:  Jessica Felton; Shien Hu; Jean-Pierre Raufman
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

9.  Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.

Authors:  Kamdeo K Pramanik; Abhay K Singh; Manzar Alam; Tanushree Kashyap; Prajna Mishra; Aditya K Panda; Ratan K Dey; Ajay Rana; Siddavaram Nagini; Rajakishore Mishra
Journal:  Tumour Biol       Date:  2016-09-30

10.  miR-21 inhibitor suppresses proliferation and migration of nasopharyngeal carcinoma cells through down-regulation of BCL2 expression.

Authors:  Yumei Li; Limei Yan; Wenyu Zhang; Hui Wang; Wei Chen; Nan Hu; Hesheng Ou
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.